Targeted therapies in AML: Evolving concepts for AML

被引：0
|
作者：
Serve, H. [1 ]
机构：
[1] Goethe Univ Frankfurt, Med Klin 2, Frankfurt, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [41] Systematic Combinatorial Chimeric Antigen Receptor Therapies to AML
    Perna, Fabiana
    Berman, Samuel
    Soni, Rajesh K.
    Mansilla-Soto, Jorge
    Eyquem, Justin
    Hamieh, Mohamad
    Hendrickson, Ronald C.
    Brennan, Cameron
    Sadelain, Michel
    BLOOD, 2017, 130
  • [42] Combination therapies targeting apoptosis pathways in paediatric AML
    Ali, A.
    Lappin, K.
    Blayney, J.
    Mills, K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 53 - 53
  • [43] DO DIFFERENT THERAPIES OF AML PRODUCE DIFFERENT OUTCOMES
    GALE, RP
    LEE, ML
    LEUKEMIA RESEARCH, 1990, 14 (03) : 207 - 208
  • [44] IREM-1 is a cell surface receptor expressed in AML blasts: Potential for targeted immumotherapy in AML
    Zhao, Xiaoxian
    Korver, Wouter
    Singh, Shweta
    Hsi, Eric D.
    Abo, Arie
    BLOOD, 2007, 110 (11) : 531A - 532A
  • [45] Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival
    Badar, Talha
    Atallah, Ehab
    Shallis, Rory M.
    Goldberg, Aaron D.
    Patel, Anand
    Abaza, Yasmin
    Bewersdorf, Jan P.
    Saliba, Antoine N.
    Correia, Guilherme Sacchi De Camargo
    Murthy, Guru
    Duvall, Adam
    Burkart, Madelyn
    Stahl, Maximilian
    Liu, Yuanhang
    Dinner, Shira
    Palmisiano, Neil
    Litzow, Mark R.
    Foran, James M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) : E232 - E235
  • [46] TREATMENT-RELATED AML AND AML EVOLVING FROM MDS: SIMILAR OUTCOMES FOLLOWING TREATMENT WITH AMONAFIDE plus CYTARABINE
    Sekeres, M.
    Allen, S.
    Mohan, S.
    Lundberg, A.
    Erba, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 273 - 273
  • [47] Antibody targeted chemotherapy in AML-MRC experience
    Burnett, A. K.
    ANNALS OF HEMATOLOGY, 2008, 87 : S94 - S94
  • [48] MicroRNA-155 expression and function in AML: An evolving paradigm
    Narayan, Nisha
    Bracken, Cameron P.
    Ekert, Paul G.
    EXPERIMENTAL HEMATOLOGY, 2018, 62 : 1 - 6
  • [49] Targeted Therapy of FLT3 mutated AML
    Fiedler, W.
    Heuser, M.
    Kayser, S.
    Kebenko, M.
    Krauter, J.
    Salih, H. R.
    Goetze, K.
    Stamm, H.
    Latuske, E.
    Wellbrock, J.
    Doehner, K.
    Ganser, A.
    Doehner, H.
    Schlenk, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 21 - 21
  • [50] Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment
    Banella, Cristina
    Catalano, Gianfranco
    Travaglini, Serena
    Pelosi, Elvira
    Ottone, Tiziana
    Zaza, Alessandra
    Guerrera, Gisella
    Angelini, Daniela Francesca
    Niscola, Pasquale
    Divona, Mariadomenica
    Battistini, Luca
    Screnci, Maria
    Ammatuna, Emanuele
    Testa, Ugo
    Nervi, Clara
    Voso, Maria Teresa
    Noguera, Nelida Ines
    CANCERS, 2022, 14 (10)
12345